Galantamine Hydrobromide contains not less than 98.0% and not more than 102.0% of C17H21NO3‧HBr, calculated on the dried basis.

共有 1 個藥物證書使用此成份

葛蘭他命
Galantamine Hydrobromide

• 申請商: 新雙隆生技股份有限公司
• 適應症: 阿茲海默氏症治療用藥
• 發證日期: 2013-03-25